• Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder
  • Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder
  • Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder
  • Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder
  • Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder
  • Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder

Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder

Powder: Yes
Customized: Ready to Ship
Certification: GMP, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 1/g 1 g(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory
  • Overview
  • Packaging & Shipping
  • Our Advantages
  • FAQ
Overview

Basic Info.

Other Name
(Arry-470)
Sample
Free
Application
for Antibacteria
Impurity
0.01%
Assay
99.5%
Residual Solvent
Ethanol
Annul Sales
2000kg
Heavy Metal
10ppm
Capacity
2500kg
Stock
2.00kg
Water
0.01%
Market
India
Ever Exported?
Yes
Volume
200kg
Experience
10years
Transport Package
Air
Specification
10g 50g 100g 1kg 25kg 100kg 500kg
Trademark
Jinan Jianfeng
Origin
Shandong, China
HS Code
2934999988
Production Capacity
5000kg

Product Description

Lapatinib ditosylate powder cas 388082-78-8
If you are looking to buy top qulity Lapatinib ditosylate online,please contact us for the lowest price in the market now!!
Breast cancer remains a leading cause of disease and death among women throughout the world. Despite advances in drug therapy, development of novel and improved drugs for breast cancer continues to be of great interest. Lapatinib is a novel dual receptor tyrosine kinase inhibitor that is a selective and potent inhibitor of ErbB-1 and ErbB-2 tyrosine kinases, both of which are growth promoting factors overexpressed in some breast cancers.
Lapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It is present as the monohydrate of the ditosylate salt (trade name TYKERB). Lapatinib is dual inhibitor of the EGFR (epidermal receptor; also called HER1 or ErbB1) and HER2 receptor tyrosine kinases. Lapatinib was developed by GlaxoSmithKline, however, Novartis subsequently acquired all the rights to the drug from GlaxoSmithKline. TYKERB is indicated in combination therapy for the treatment of metastatic breast cancer that overexpresses the HER2 receptor.

 
 
CAS NO 388082-78-8
Appearance white crystalline powder
Molecular weight 925.46
Molecular formula C41H40ClFN4O11S3

Packaging & Shipping

1. Mass stock, to make sure delivery promptly every day when the payment is done.

2. Having been engaged in this field for years, we have sophisticated and professional logistics department, which can guarantee safe and speedy delivery.Transit could be UPS,TNT,EMS,Fedex,and so on.

3.Depending on your location, clear customs safely and deliver to your door in 3-5 days.
Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder

 

Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder
Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder


 

Our Advantages

Jinan Jianfeng Chemical Co., Ltd is a research-driven pharmaceutical company. Established in 2011, we have more than 10 years experience in the pharmacy filed. In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System. Our products meet USP, EP standards and are exported to US, Germany, Canada, Japan, etc. For better production, Jianfeng has set up advanced labs and factories. 

 

We are a well-known pharmaceutical intermediate manufacturer in China, with a complete production system and quality management system, and the warehouse has sufficient stock, which can be shipped on the same day of payment. Simultaneous sales in multiple channels at home and abroad, online and offline .Supply 99% Purity Chemicals Product Anticancer Lapatinib Ditosylate Powder

FAQ

Q1: Are you the manufacturer or trader?

--We are the manufacturer in China, founded in 2011.


Q2: When will the product be shipped after payment?

--Product is ready any second with or without payment. Ready to Go!

 

Q3: Which kind of payment terms do you accept?

 ---For small order,you can pay by T/T, trade assurance or Paypal, commercial order by T/T to our company account.

 

Q4: How does your factory control quality?

---All the raw material purchasing and production quality control are strictly following the ISO9001: 2008 management system. Besides, the full-featured detection equipment and GMP quality management system provided the strongest guarantee for a high-quality product. 

 

Q5: What is your package?

---Powder: PE bag, glass bottle, or PTFE bottle for inner packing, and aluminum foil bag for outer packing.

    Liquid: glass bottle or PTFE bottle for inner packing, and aluminum foil bag for outer packing.

    Bulk order: Fiber drum or steel drum.

 

Q6: How long will it take to receive the parcel?

 ---3-5 days for the US market; 4-6 days for the others.

 

Q7: What can I do if I don't have the ability to clear the custom?

 ---We got experience after doing export for many years, so don't worry we can handle that.

 

Q8: Can I get some samples?

 ---Yes, we can supply the free sample, but the shipping cost be paid by customers.

 

Q9: How to contact us ?

---You can chat with us by Trade manager, WhatsApp&Skype Online.

You can choose your interested products and send inquiry to us. You can dial our telephone directly or send email to me, you will get our reply. 

We are looking forward to your inquiry

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory
Number of Employees
13
Year of Establishment
2011-07-26